Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Willow Biosciences Inc T.WLLW

Alternate Symbol(s):  CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial... see more

TSX:WLLW - Post Discussion

Willow Biosciences Inc > Cellular goods and Willow
View:
Post by new2stox on Mar 07, 2021 5:09pm

Cellular goods and Willow

Check out the Cellular goods  propspectus. In it WLLW is cited as being one of four principal suppliers of cannabinoids for Cellular Goods (see page 11)

https://www.cellulargoods.co/static/CG_Prospectus.PDF

I wonder if this was considered when they decided to start production at a European facility?
Comment by BoatyMcBoatface on Mar 07, 2021 7:35pm
This is obviously great.  Doesn't WLLW have to report this sort of thing? How on Earth did you come across this? Good investigation!
Comment by Beluga2020 on Mar 09, 2021 2:53pm
This is a very good question. Why wasn't this supply agreement announced by Willow? Has anyone been in contact with the company on this topic? Unsure why they would avoid a positive news release. Perhaps they want to bundle multiple agreements into one announcement
Comment by vermock123 on Mar 09, 2021 4:05pm
I think they will release required information at quater end report.
Comment by jermiah777 on Mar 08, 2021 1:00am
Incredible...thanks for the research. I will quote the key points in article below. Contracts 16.1 In order to give effect to its business plan, the Company has entered into term sheets or agreements with the following parties for the supply of CBD, and with a CMO for manufacturing of the Companys beautycare products: (a) Purisys LLC (www.purisys.com) Purisys is an ingredient and solutions ...more  
Comment by lscfa on Mar 08, 2021 1:10am
12.2.4 On 28 January 2021 the Company entered into a term sheet with Willow Biosciences, Inc. pursuant to which the parties have agreed to enter into a one year supply agreement under which Willow Biosciences, Inc. will supply bio-synthetic cannabinoids to the Company. In consideration of the services provided to the Company, the Company will pay Willow Biosciences, Inc. an agreed rate per KG ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities